Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate in Coronary Heart Disease with LDL-C at Goal
NCT00552747Phase 4Completed
- Start
- Oct 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary heart disease (CHD) and hyperlipidemia comparing fenofibrate with placebo (2 arms). Primary endpoint: Endothelial function at 8 weeks. Started Oct 2007; status: completed.
02
Drugs
fenofibrate
03
Conditions
coronary heart disease (CHD)hyperlipidemia
Beyond the preview
Go deeper on NCT00552747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00552747.